We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Merck KGaA (PK) | USOTC:MKKGY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 32.72 | 32.98 | 33.25 | 2 | 13:43:12 |
From May 2019 to May 2024
By Olivia Bugault
Merck KGaA's venture-capital arm M Ventures has been part of a 10 million euros ($10.8 million) seed round for FoRx Therapeutics, which is developing new cancer drugs.
Biotechnology company FoRx Therapeutics said Wednesday that M ventures, Novartis Venture Fund, Omega Funds, Life Sciences Partners and Pfizer Ventures participated in the funding round that is now closed.
FoRx Therapeutics is developing drugs targeting DNA replication stress for cancer, it said.
Write to Olivia Bugault at olivia.bugault@wsj.com
(END) Dow Jones Newswires
April 22, 2020 09:28 ET (13:28 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Merck KGaA (PK) Chart |
1 Month Merck KGaA (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
